An interventional study of APP-based multifaceted management in Percutaneous Coronary Intervention, sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital. Status unknown. Per ClinicalTrials.gov, last updated 2017-02-23.
Sponsored by Chinese Academy of Medical Sciences, Fuwai Hospital · Not applicable, Interventional, and Other
High rates of recurrent cardiovascular events and readmission after percutaneous coronary intervention (PCI) are important issues. Guidelines emphasize rehabilitation and secondary prevention. But many patients are lack of effective management after PCI.This study is aimed to examine the effect of mobile application (APP)-based multifaceted management on the improvement of long-term care after PCI.
This is a cluster-randomized controlled trial to evaluate the effect of APP-based multifaceted management strategy on improvement of long-term care for medication adherence,risk factor control, and reduction of adverse events, readmission rate and mortality after PCI.It includes knowledge education, medication reminder,advice provision, support to change lifestyle behaviors. The program is interactive between care provider and patients. A total of 20 wards will be randomly assigned to intervention or usual care.Anticipated 1100 patients after PCI will be participated in the trial. All the participants will be followed up until 12 months.
Chinese Academy of Medical Sciences, Fuwai Hospital is the lead sponsor of 141 studies on the registry; 48 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
APP-based multifaceted management, including sending education material, everyday medication reminder, giving risk factor control support, clinical support to patients after PCI through APP.
Other: APP-based multifaceted management
usual care without APP
Patients after PCI will be regularly given education materials, medication reminders, life-style behaviors instruction through APP. Cardiologists can interact with patients on advice provision and clinical support after discharge through APP.
evidence-based medication adherence (the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications)
the proportion of participants taking 3 medications (aspirin, P2Y12 receptor inhibitor, statin) without contraindications
Time frame: at 12 months after PCI
rate of LDL-C achieving target
rate of LDL-C achieving target based on guideline
Time frame: at 12 months after PCI
rate of systolic blood pressure achieving target
rate of systolic blood pressure achieving target based on guideline
Time frame: at 12 months after PCI
readmission rate
readmission rate after PCI
Time frame: 12 months after PCI
smoking status (the proportion of participants with smoking cessation)
the proportion of participants with smoking cessation
Time frame: at 12 months after PCI
rehabilitation (the proportion of participants who receive rehabilitation program)
the proportion of participants who receive rehabilitation program
Time frame: 12 months after PCI
No study locations are listed for this record.
Plan to share: Yes — management methods,outcomes including medication use, events of patients can be available on request.
This study is status unknown, as verified in Feb 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Chinese Academy of Medical Sciences, Fuwai Hospital